During the past decade, Gramercy Research Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gramercy Research Group" #1 collaborator was "University of North Carolina, Chapel Hill" with 2 trials as a collaborator, "Arizona State University" with 1 trials as a collaborator, "Kaiser Permanente" with 1 trials as a collaborator, "Montana State University" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Gramercy Research Group" are "Chronic Disease" (1 trials), "Diabetes" (1 trials), "Hypertension" (1 trials), "Lack of Physical Activity" (1 trials) and "Medication Adherence" (1 trials). Many other conditions were trialed in "Gramercy Research Group" in a lesser frequency.

Most popular intervention types in "Gramercy Research Group" are "Behavioral" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active and Healthy Brotherhood (AHB)" (1 trials), "Faith-based" (1 trials), "Focus group" (1 trials), "GTX-006 (Acapodene)" (1 trials) and "Non-faith-based" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gramercy Research Group" are 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Gramercy Research Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Gramercy Research Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gramercy Research Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".